Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece
- PMID: 32558015
- PMCID: PMC7323240
- DOI: 10.1111/jdv.16759
Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece
Conflict of interest statement
Dr. Vakirlis, Dr. Bakirtzi, Dr. Papadimitriou, Dr. Vrani, Dr. Sideris, Dr. Lallas Dr. Ioannides and Dr. Sotiriou have nothing to disclose.
References
-
- Arnold T, Schaarschmidt ML, Herr R, Fischer JE, Goerdt S, Peitsch WK. Drug survival rates and reasons for drug discontinuation in psoriasis. J Dtsch Dermatol Ges 2016; 14: 1089–1099. - PubMed
-
- D'Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl 2020; 26: 832–834. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
